Securities Code: 002653
Securities Abbreviation: Haes科
Announcement No.: 2026-088
Haes科 Pharmaceutical Group Co., Ltd.
Report on Changes in Shareholding of Directors and Senior Management
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, without false records, misleading statements, or major omissions.
According to the "Approval for the Registration of the Issuance of Shares by Haes科 Pharmaceutical Group Co., Ltd. to Specific Objects" (Regulatory Permit (2026) No. 78) issued by the China Securities Regulatory Commission, Haes科 Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") issued 20,974,510 A-shares to specific objects. The Company's total share capital increased from 1,119,917,970 shares to 1,140,892,480 shares.
The current directors and senior management of the Company did not participate in this issuance. Before and after this issuance, the shareholding numbers of the Company